Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edward J Stepanski

Showing results (41-50 of 48) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 48 results.
Psycho-Oncology|January 22, 2016
Analysis of the psychological impact of cancer-related symptoms on patients with non-small cell lung cancerMark S Walker, Gerhardt M Pohl, Arthur C Houts, et al.
Clinical Breast Cancer|November 26, 2013
Phase II trial of fulvestrant with metronomic capecitabine for postmenopausal women with hormone receptor-positive, HER2-negative metastatic breast cancerLee S Schwartzberg, Grace Wang, Bradley G Somer, et al.
Pancreas|June 16, 2012
The association of rash severity with overall survival: findings from patients receiving erlotinib for pancreatic cancer in the community settingEdward J Stepanski, Carolina Reyes, Mark S Walker, et al.
Sleep|February 3, 2005
Derivation of research diagnostic criteria for insomnia: report of an American Academy of Sleep Medicine Work GroupJack D Edinger, Michael H Bonnet, Richard R Bootzin, et al.
Journal of Clinical Sleep Medicine : JCSM : Official Publication of the American Academy of Sleep Medicine|June 15, 2007
The scoring of cardiac events during sleepSean M Caples, Carol L Rosen, Win K Shen, et al.
Cancer|August 24, 2017
Results of a prospective phase 2 study of pazopanib in patients with advanced intermediate-grade or high-grade liposarcomaBrian L Samuels, Sant P Chawla, Neeta Somaiah, et al.
Archives of General Psychiatry|June 8, 2011
Testing the reliability and validity of DSM-IV-TR and ICSD-2 insomnia diagnoses. Results of a multitrait-multimethod analysisJack D Edinger, James K Wyatt, Edward J Stepanski, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 28, 2013
Sorafenib or placebo with either gemcitabine or capecitabine in patients with HER-2-negative advanced breast cancer that progressed during or after bevacizumabLee S Schwartzberg, Kurt W Tauer, Robert C Hermann, et al.
Pageof 5

Showing results (41-50 of 48) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
Psycho-Oncology|January 22, 2016
Analysis of the psychological impact of cancer-related symptoms on patients with non-small cell lung cancerMark S Walker, Gerhardt M Pohl, Arthur C Houts, et al.
Clinical Breast Cancer|November 26, 2013
Phase II trial of fulvestrant with metronomic capecitabine for postmenopausal women with hormone receptor-positive, HER2-negative metastatic breast cancerLee S Schwartzberg, Grace Wang, Bradley G Somer, et al.
Pancreas|June 16, 2012
The association of rash severity with overall survival: findings from patients receiving erlotinib for pancreatic cancer in the community settingEdward J Stepanski, Carolina Reyes, Mark S Walker, et al.
Sleep|February 3, 2005
Derivation of research diagnostic criteria for insomnia: report of an American Academy of Sleep Medicine Work GroupJack D Edinger, Michael H Bonnet, Richard R Bootzin, et al.
Journal of Clinical Sleep Medicine : JCSM : Official Publication of the American Academy of Sleep Medicine|June 15, 2007
The scoring of cardiac events during sleepSean M Caples, Carol L Rosen, Win K Shen, et al.
Cancer|August 24, 2017
Results of a prospective phase 2 study of pazopanib in patients with advanced intermediate-grade or high-grade liposarcomaBrian L Samuels, Sant P Chawla, Neeta Somaiah, et al.
Archives of General Psychiatry|June 8, 2011
Testing the reliability and validity of DSM-IV-TR and ICSD-2 insomnia diagnoses. Results of a multitrait-multimethod analysisJack D Edinger, James K Wyatt, Edward J Stepanski, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 28, 2013
Sorafenib or placebo with either gemcitabine or capecitabine in patients with HER-2-negative advanced breast cancer that progressed during or after bevacizumabLee S Schwartzberg, Kurt W Tauer, Robert C Hermann, et al.
Pageof 5